BlogUniversity of Manchester technology to aid development of anti-fibrotic drugs

University of Manchester technology to aid development of anti-fibrotic drugs

Professor Karl Kadler and his team have developed technology which has the ability to monitor, quantitate and observe new collagen synthesis, on the background of existing collagen and under normal genetic control.

Currently, there are no drugs on the market that regulate collagen.

Professor Kadler comments: “Research into finding a treatment of fibrosis can benefit the most. There are no current therapies for fibroproliferative disease, which can affect any organ system leading to death and is a complicating factor in 45% of all deaths including cancer.

“Collagen is very strong and forms bone, cartilage, skin, and tendons,” continues Professor Kadler.

“Collagen fibrils, which account for 30% of the mass of vertebrates and are the mechanical framework for all fibrous and hard tissues, as well as organs such as skin, gut and muscle – are also the end-point of fibrosis (e.g. of heart, lung, liver, skin and kidney) in which functional tissue is replaced by collagen that shouldn’t be there.”

He added, “As a simple analogy, think of collagen as the walls in a building; they are essential for holding up the roof and giving the building its shape and strength but additional walls cutting across rooms and corridors makes the building unusable.  Too much collagen in lungs, heart and liver stops these organs from working”.

“We want to understand how and where collagen fibrils are assembled with the aim of controlling this process in the treatment of fibrotic disease.”

The solution appears simple, let’s find a way of stopping our bodies making too much collagen, but it isn’t that easy.  Professor Kadler suggests, “Understanding how collagen is produced, processed and regulated by cells is key to the development of new treatment strategies, however it is currently impossible to quantitatively image the process. The hurdle to overcome is to visualise new collagen (the fibrotic, bad collagen) on top of the existing (good) collagen.  Our approach allows us to visualise the new collagen in the presence of existing collagen in the presence of candidate anti-fibrotic drugs.

Explaining the technology, he said: “We have used the latest genome editing technology to integrate a photo switchable marker in the collagen protein. This does not disrupt the endogenous wild type regulation of collagen, but the photo switchable nature of this marker allows us to differentiate newly deposited collagen from previously deposited collagen.

“This is achieved by simply exposing the cells to a specific wavelength of light. This platform allows the quantitative study of collagen production in health and disease as well as the evaluation of modulators of collagen production with potential anti-fibrotic use.”

Professor Kadler said the technology “is the first tool to measure new collagen synthesis in the fight against fibrosis.”

Latest

Terence Ang Takes AI-Narrated Poetry to NCTE 2026 Following International Award Wins

Singaporean author living with aphasia will showcase award-winning audiobook Brokenness Becomes Beautiful in Philadelphia, bringing disability inclusion, technology and creative expression into focus. A Singaporean...

Former HCA Healthcare technology chief joins SciSure Board

Life sciences software provider SciSure has strengthened its Board of Directors with the appointment of Marty Paslick, who brings more than three decades of...

WellBox launches milestone gifting platform for employers

WellBox, the B Corp certified corporate gifting company, has launched milestone gifting, a platform that helps employers mark work anniversaries, birthdays and other career...

Avensure Reaches 15-Year Milestone as Client Base Exceeds 7,000 Businesses

The Manchester-founded HR, employment law and health & safety company celebrates nationwide growth, strong review scores and further investment in its services and technology. Avensure...
Subscribe to our newsletter
Business Manchester will use the information you provide on this form to be in touch with you and to provide updates and marketing.
Don't miss

Sexual violence campaigner criticises response to Russell Brand case and calls for justice system reform

A sexual violence campaigner has called for greater accountability in the criminal justice system after expressing concern that Russell Brand's continued denial of guilt,...

Salary transparency puts employer culture and leadership under the spotlight

Pay is becoming a more open part of the recruitment process across Europe, but employers may find that publishing salary information is only the...

St Helens online retailer launches with free UK-wide kitchen worktop delivery and AI phone agent

A new online kitchen worktop retailer based in Rainford, St Helens, has launched, offering homeowners and kitchen fitters across the UK more than 190...

Best Christmas gifts for women 2026: Our festive gift guide

Christmas shopping can be great fun, but finding the right gifts for all the women in your life isn't always quite so easy. Whether...

More News

At Liberatum Venice, filmmakers explore how cinema can push back against online judgment

Bruno Wang joined Lee Daniels, Nadine Labaki and Marisa Berenson for a Liberatum-curated conversation about restoring context and humanity in an age of instant...

Ritherdon’s Latest Fire Safety Innovation Receives High Praise from Industry Leader

A major UK supplier serving the construction and fire protection industries has given a strong endorsement to Ritherdon’s latest passive fire safety innovation, describing...

Vega Introduces Detection Skills, The New Open Standard for AI Reasoning in Agentic Cyber Defense

Transforms static detection rules into a continuously improving agentic loop. Open to every Cyber Defender at detectionskills.io, natively integrated on Vega platform. LAS VEGAS –...